Kyverna Therapeutics OverviewKyverna Therapeutics Other Income Expense Net
Other Income/Expense Net for KYTX.
Quarterly Other Income/Expense
$1.64M
↓ 40.89% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$7.39M
↓ 51.52% YoY
Trailing 12 months ending Mar 31, 2026